Regis Healthcare Ltd (ASX: REG) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Regis Healthcare Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $610.58 million
P/E Ratio 238.10
Dividend Yield 0.95%
Shares Outstanding 300.78 million
Earnings per share 0.009
Dividend per share 0.02
Year To Date Return 12.70%
Earnings Yield 0.42%
Franking 50%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

Regis Healthcare Ltd (ASX: REG)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
10 Mar 2021 $0.0200 50.00% Interim 08 Apr 2021
11 Mar 2020 $0.0402 50.00% Interim 30 Sep 2020
11 Sep 2019 $0.0711 100.00% Final 26 Sep 2019
13 Mar 2019 $0.0812 100.00% Interim 11 Apr 2019
11 Sep 2018 $0.0865 100.00% Final 26 Sep 2018
13 Mar 2018 $0.0928 100.00% Interim 11 Apr 2018
01 Sep 2017 $0.1004 100.00% Final 18 Sep 2017
03 Mar 2017 $0.1030 100.00% Interim 20 Mar 2017
02 Sep 2016 $0.0594 100.00% Final 19 Sep 2016
03 Mar 2016 $0.0940 100.00% Interim 21 Mar 2016
03 Sep 2015 $0.1760 64.20% 21 Sep 2015

REG ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Regis Healthcare Ltd

Regis Healthcare Ltd provides residential care for the elderly in Australia, including respite, dementia-specific, and palliative care. The firm's facilities are primarily located in metropolitan areas and a majority of its rooms offered are single bedrooms. The majority of Regis' revenue comes from government funding due to the highly regulated environment for aged care facilities in Australia, though the firm also receives resident fees. The geographies that contribute thelargest proportion of revenue are Queensland and Victoria.

REG Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
03 Aug 2021 $2.10 $-0.01 -0.47% 283,246 $2.12 $2.12 $2.07
02 Aug 2021 $2.11 $0.03 1.44% 170,190 $2.08 $2.11 $2.06
30 Jul 2021 $2.08 $-0.05 -2.35% 155,378 $2.12 $2.16 $2.07
29 Jul 2021 $2.13 $-0.03 -1.39% 142,527 $2.14 $2.18 $2.13
28 Jul 2021 $2.16 $0.01 0.47% 520,687 $2.15 $2.21 $2.09
27 Jul 2021 $2.15 $0.24 12.57% 1,328,408 $2.00 $2.15 $1.97
26 Jul 2021 $1.91 $0.00 0.00% 100,076 $1.91 $1.95 $1.91
23 Jul 2021 $1.91 $0.01 0.53% 236,717 $1.91 $1.93 $1.89
22 Jul 2021 $1.90 $-0.02 -1.04% 57,185 $1.90 $1.93 $1.90
21 Jul 2021 $1.92 $0.03 1.59% 227,720 $1.89 $1.94 $1.89
20 Jul 2021 $1.89 $-0.02 -1.05% 1,143,239 $1.90 $1.92 $1.87
19 Jul 2021 $1.91 $-0.06 -3.05% 226,588 $1.95 $1.96 $1.91
16 Jul 2021 $1.97 $-0.02 -1.01% 228,492 $1.95 $2.01 $1.94
15 Jul 2021 $1.99 $0.02 1.02% 410,337 $1.96 $2.03 $1.95
14 Jul 2021 $1.97 $0.03 1.55% 402,135 $1.92 $2.02 $1.91
13 Jul 2021 $1.94 $0.03 1.57% 215,271 $1.90 $1.96 $1.90
12 Jul 2021 $1.91 $-0.02 -1.04% 1,055,399 $1.94 $1.94 $1.89
09 Jul 2021 $1.93 $-0.02 -1.03% 105,826 $1.95 $1.99 $1.92
08 Jul 2021 $1.95 $-0.04 -2.02% 1,601,709 $1.99 $2.01 $1.95
07 Jul 2021 $1.99 $0.04 2.05% 157,687 $1.95 $2.00 $1.94
06 Jul 2021 $1.95 $0.00 0.00% 224,878 $1.95 $1.97 $1.93

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
01 Oct 2020 Christine Bennett Buy 21 $24,768
On-market trade.
28 Sep 2020 Matthew Quinn Buy 20 $20,964
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Graham Hodges Non-Executive DirectorNon-Executive Chairman Aug 2017
Mr Hodges has international experience in the financial services industry with a career spanning more than 35 years. He commenced his career in Commonwealth Treasury, Canberra where he worked for approximately 10 years before being seconded to the International Monetary Fund in Washington for several years. For 28 years, Graham built an executive career at the Australian and New Zealand Banking Group Limited and most recently was the Deputy Chief Executive Officer, ANZ Banking Group Ltd. Graham is currently a Director of AmBank and Assemble Communities Pty Ltd as Nominee of Assemble Holdco 1 Pty Ltd, and was previously Chairman of ANZ SAM Board (Special Assets Management) and Director of Esanda, ANZ Wealth, and the Government's Aged Care Financing Authority.
Mr Matthew James Quinn Non-Executive Director Mar 2018
Mr Quinn has a track record of strategy development, delivering financial results and driving operational efficiency as a senior real estate and property development executive. This, together with his understanding of strategic M&A, capital markets and regulatory environments enables him to make a contribution to the Board. Matthew was Managing Director of Stockland for 13 years and is currently a Non-Executive Director of CSR Limited and Elders Limited, and Chairman of Class Limited and TSA Management Group Holdings Pty Ltd. Matthew is Chairman of the People Committee.
Professor Christine Constance Bennett Non-Executive Director Mar 2018
Prof Bennett is a specialist paediatrician with over 30 years health industry experience in clinical care and governance, strategic planning, executive management, teaching and research. She is Deputy Vice Chancellor and Head of Campus, Sydney at the University of Notre Dame Australia. Christine is also Convenor of the Male Champions of Change Health Group. Previously Christine has been the Dean, School of Medicine, Sydney at the University of Notre Dame Australia, a Group Executive and Chief Medical Officer at both MBF Limited and Bupa Australia, a partner in the KPMG Health and Life Sciences practice, CEO of Westmead Hospital, Chair of the Sydney Children's Hospitals Network and non-executive director of Digital Health CRC Limited. From 2008 to 2010, Christine was Chair of the National Health and Hospitals Reform Commission to provide advice on a long term plan for the future of the Australian health system and aged care. Christine was awarded an Officer of the Order of Australia in recognition of her distinguished service to medicine and health care leadership in 2014. Christine is Chairman of the Clinical Governance and Care Committee.
Ms Sylvia Falzon Non-Executive Director Sep 2014
Ms Falzon brings to Regis valuable experience in the areas of business development, marketing, brand management, customer service, risk & compliance together with remuneration and people strategies. Sylvia has held senior executive positions within the financial services industry over a 30-year career. Through her executive and non-executive career, she has gained experience working in large consumer-facing and regulated businesses within the financial services, healthcare, retail and aged care sectors. Sylvia is also Chairman of Cabrini Australia, a large not for profit health, technology and outreach organisation and was formerly Non-Executive Director of Perpetual Limited. Sylvia is Chairman of the Risk and Compliance Committee
Mr Bryan Dorman Non-Executive Director May 2007
Mr Dorman had been a Director of Fairway Investment Holdings Pty Ltd since May 2007. Bryan has experience working in and growing enterprises across a broad range of industry sectors, including residential aged care, manufacturing, property development asset investment, and business services. Bryan was a partner in Melbourne accounting firm Rees Partners from 1977 until 2000 and is a qualified accountant. Bryan was also the National President of the former aged care industry body, The Aged Care Association of Australia, from 2004 to 2012, and was actively involved in the development of the industry and shaping its future.
Mr Ian Gregory Roberts Non-Executive Director May 2007
Mr Roberts had been a director of Fairway Investment Holdings Pty Ltd since May 2007. Ian has over 30 years experience in the real estate sector including 20 years in residential aged care. Prior to co-leading the Regis journey, Ian was involved in property development (sub-divisional and commercial) in South East Queensland. As a founding shareholder and Director of Regis (Executive Director prior to 2008), Ian headed up the property division with oversight of the development and implementation of the strategy that saw the business grow to in excess of 4,500 beds nationally. Ian is currently a Non-Executive Director of several property and property services enterprises.
Dr Linda Jane Mellors Chief Executive OfficerManaging Director Aug 2019
Dr Mellors has more than 15 years Executive experience in health and aged care. Prior to joining Regis, she was Chief Executive - Health Services and Chief Operating Officer of Mercy Health, where she led acute, sub-acute, residential aged care, home care, retirement living, mental health and palliative care services. Linda was also the Co-Chair of the Victorian Metropolitan Chief Executive group. Linda is currently a Board Director of Mackillop Family Services. She was formerly Chair of the North Eastern Metropolitan Integrated Cancer Service, Board Member of the Parent Infant Research Institute and Board Director of the South West Melbourne Medicare Local. Linda has recently been appointed Chair of the Aged Care Guild, an association formed by private residential aged care providers committed to the future of aged care in Australia.
Ms Rebecca Dean Company Secretary Jul 2020
-
Rick Rostolis Chief Financial Officer
-
Rebecca Dean Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Ashburn Pty Ltd 81,910,479 27.24%
Galabay Pty Ltd 81,910,479 27.24%
Hsbc Custody Nominees (Australia) Limited 28,622,874 9.52%
J P Morgan Nominees Australia Pty Limited 18,385,823 6.11%
Citicorp Nominees Pty Limited 15,150,565 5.04%
BNP Paribas Noms Pty Ltd 4,916,872 1.63%
Mr David Qian Lee 4,823,888 1.60%
BNP Paribas Nominees Pty Ltd 3,678,045 1.22%
Mr Ross James Johnston 2,800,001 0.93%
National Nominees Limited 2,530,242 0.84%
Mr Vincent Michael O'Sullivan 2,030,000 0.67%
BKI Investment Company Limited 1,807,428 0.60%
Jenny Lynn Properties Pty Ltd 1,464,866 0.49%
Bundarra Trading Company Pty Ltd 852,671 0.28%
Hsbc Custody Nominees (Australia) Limited I 850,000 0.28%
Ballian Investments Pty Ltd 787,934 0.26%
SEP Super Pty Ltd 748,830 0.25%
Australian Executor Trustees Limited 722,170 0.24%
Buttonwood Nominees Pty Ltd 575,590 0.19%
Netwealth Investments Limited 439,284 0.15%

Profile

since

Note